Tetra Bio-Pharma Secures Financing for Hemp Energy Drink Business
OTTAWA, Nov. 18, 2019 (GLOBE NEWSWIRE) — Tetra Bio-Pharma Inc., (TSX-V: TBP) (OTCQB: TBPMF), a leader in drug discovery and […]
Harte Hanks Announces New Leadership Appointments to Energize Growth and Accelerate Strategic Transformation
Andrew Benett, Former Global CEO of Havas Creative Group,Appointed as Executive Chairman and CEOBrian Linscott named COO and Lauri Kearnes […]
Meritage Homes to Host Analyst Meeting on November 19, 2019
SCOTTSDALE, Ariz., Nov. 18, 2019 (GLOBE NEWSWIRE) — Meritage Homes Corporation (NYSE:MTH), a leading U.S. homebuilder, will host an Analyst […]
Integer Updates 2019 Guidance Following Customer Chapter 11 Filing, No change in prior view of 2020 sales outlook
PLANO, Texas, Nov. 18, 2019 (GLOBE NEWSWIRE) — Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource manufacturer, today announced […]
Gold Lion Provides Corporate Update and 2020 Operational Guidance
VANCOUVER, British Columbia, Nov. 18, 2019 (GLOBE NEWSWIRE) — Gold Lion Resources Inc. (“Gold Lion” or the “Company”) (CSE: GL), a growth oriented […]
Discovery Metals Announces Trading on the OTCQX Market
TORONTO, Nov. 18, 2019 (GLOBE NEWSWIRE) — OTCQX® Best Market in the United States under the symbol DSVMF, effective today.Taj […]
TSX News -
ProMIS Neurosciences Completes First Closing of Private Placement
NOT FOR DISTRIBUTION TO US NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTORONTO, Nov. 18, 2019 (GLOBE NEWSWIRE) — […]
Fireweed Zinc Receives Upgraded Permit for Macmillan Pass
VANCOUVER, British Columbia, Nov. 18, 2019 (GLOBE NEWSWIRE) — FIREWEED ZINC LTD. (“Fireweed” or the “Company”) (TSXV: FWZ) is pleased […]
Lumina Gold Secures Key Land For Project Development
Highlights:400.5 hectares of land secured for facility siting and other uses79.5 hectares of land secured to the north of Gran […]
Matinas BioPharma to Present at the 31st Annual Piper Jaffray Healthcare Conference
BEDMINSTER, N.J., Nov. 18, 2019 (GLOBE NEWSWIRE) — Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical stage biopharmaceutical company, […]
